Literature DB >> 21592015

Horizontal gaze palsy and progressive scoliosis due to a deleterious mutation in ROBO3.

Khaled K Abu-Amero1, Seema Kapoor, Ali Hellani, Sumit Monga, Thomas M Bosley.   

Abstract

PURPOSE: To describe a family with horizontal gaze palsy and progressive scoliosis with a deleterious mutation in the ROBO3 gene.
METHODS: All family members had full ophthalmologic, neurologic, and orthopedic examinations and complete sequencing of the ROBO3 gene.
RESULTS: Four affected members had complete loss of horizontal gaze with progressive scoliosis that varied between family members. ROBO3 sequencing revealed a novel 15 base deletion (c.2_16 delTGCTGCGCTACCTGC) in exon 1 that segregated in homozygous form with the phenotype and probably alters the shape and ionic charge of the extracellular immunoglobulin motif 1. This mutation was not detected in 100 control chromosomes.
CONCLUSIONS: The novel ROBO3 mutation in this family may be among the most deleterious yet reported. Family members in general were severely affected, but comparison of this family to other families with ROBO3 mutations did not yield a definitive phenotype-genotype correlation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592015     DOI: 10.3109/13816810.2011.580445

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  3 in total

1.  Horizontal gaze palsy with progressive scoliosis: is scoliosis linked to ROBO3 mutations?

Authors:  Carmine Ungaro; Rosalucia Mazzei; Teresa Sprovieri
Journal:  Neurol Sci       Date:  2018-09-14       Impact factor: 3.307

Review 2.  Human disorders of axon guidance.

Authors:  Alicia A Nugent; Adrianne L Kolpak; Elizabeth C Engle
Journal:  Curr Opin Neurobiol       Date:  2012-03-05       Impact factor: 6.627

3.  Horizontal gaze palsy and scoliosis: a case report and review of the literature.

Authors:  E P Samoladas; J O'Dowd; A Cardoso-Almeida; A K Demetriades
Journal:  Hippokratia       Date:  2013-10       Impact factor: 0.471

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.